NDC 76420-906 – Lubiprostone

Lubiprostone 8 ug/1 · Capsule, Gelatin Coated · Oral

Human Prescription Drug

Product NDC76420-906

Product details

Brand name
Lubiprostone
Generic name
Lubiprostone
Labeler
Asclemed USA, Inc.
Dosage form
Capsule, Gelatin Coated
Route
Oral
Marketing category
NDA AUTHORIZED GENERIC · NDA021908
Marketed since
January 1, 2023
Listing expires
December 31, 2026
Pharmacologic class
Chloride Channel Activator

Active ingredients

Uses, dosage, side effects and warnings for Lubiprostone →

Package NDC codes (4)

Package NDCDescriptionSince
76420-906-01100 CAPSULE, GELATIN COATED in 1 BOTTLE (76420-906-01)Jan 28, 2025
76420-906-3030 CAPSULE, GELATIN COATED in 1 BOTTLE (76420-906-30)Jan 28, 2025
76420-906-6060 CAPSULE, GELATIN COATED in 1 BOTTLE (76420-906-60)Jan 28, 2025
76420-906-9090 CAPSULE, GELATIN COATED in 1 BOTTLE (76420-906-90)Jan 28, 2025

Other Lubiprostone products